Skip to main content
GLP-1(S)
Batch #910463Purity: 99.7%
Metabolic

GLP-1(S).

Semaglutide is a synthetic analog of human glucagon-like peptide-1 (GLP-1) with 94% homology to native GLP-1. With the molecular formula C₁₈₇H₂₉₁N₄₅O₅₉ and a molecular weight of 4113.6 g/mol (CAS: 910...

$48.00
Select Protocol

Lab Verified

Clinical Grade

PMID Cited

Mechanism of Action.

Published preclinical research has characterized the following molecular pathways and receptor interactions for GLP-1(S).

Gs-protein coupling

GLP-1 Receptor

Semaglutide binds to GLP-1 receptors with high affinity, activating Gs-proteins and increasing intracellular cAMP levels in beta-cell models.

Lipophilic side chain interaction

Albumin Binding

The C18 fatty di-acid side chain enables reversible albumin binding, extending circulation half-life in biochemical studies.

Endocytosis/recycling

Receptor Internalization

Published studies indicate Semaglutide promotes receptor internalization with distinct kinetics compared to native GLP-1.

Evidence Based

Clinical Literature

View All Studies
Preclinical

Research review on GLP-1(S) molecular characterization.

Preclinical studies have characterized the molecular properties and receptor binding profiles of GLP-1(S) in standardized assay systems.

Preclinical

GLP-1(S) structure-activity relationship analysis.

Structure-activity relationship studies have examined the functional domains and binding characteristics of GLP-1(S) in cell-free and cell-based systems.

RESEARCH USE ONLY: This compound is intended exclusively for in vitro laboratory research. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not evaluated by the FDA. Must be 21+ to purchase.

Scientific Context

Related Research & Analysis